An emerging cause of chronic fatigue and pain : post-COVID-19 condition or long COVID
Some individuals who have been infected with SARS-CoV-2 can experience long-term effects from their infection, known as post-COVID conditions, post-acute sequelae of COVID-19 or long COVID. Different underlying mechanisms can lead to long COVID, none of which are mutually exclusive. Lingering symptoms can persist years after SARS-CoV-2 infection, including fatigue, muscle weakness, tachycardia, dyspnea and various neurological symptoms. The symptomatology is partly similar to that reported by people with chronic fatigue syndrome and other unwell studied long-lasting diseases that may occur after other infections. People who have experienced more severe COVID-19 illness are at higher risk of developing long COVID, although anyone who was infected can experience post-COVID conditions. Importantly, unvaccinated individuals are more likely to develop long COVID. Here we review the current knowledge and discuss key findings regarding the epidemiology and physiopathology of long COVID. We briefly review current diagnostic and treatment options that remain so far largely insufficient.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
---|---|
Enthalten in: |
Revue medicale de Liege - 78(2023), 5-6 vom: Mai, Seite 299-304 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Une cause émergente de fatigue et de douleurs chroniques : l’affection post-COVID-19 ou COVID long |
---|
Beteiligte Personen: |
El Moussaoui, Majdouline [VerfasserIn] |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 26.06.2023 Date Revised 26.06.2023 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM358515890 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358515890 | ||
003 | DE-627 | ||
005 | 20231226074920.0 | ||
007 | tu | ||
008 | 231226s2023 xx ||||| 00| ||fre c | ||
028 | 5 | 2 | |a pubmed24n1195.xml |
035 | |a (DE-627)NLM358515890 | ||
035 | |a (NLM)37350206 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a El Moussaoui, Majdouline |e verfasserin |4 aut | |
245 | 1 | 3 | |a An emerging cause of chronic fatigue and pain |b post-COVID-19 condition or long COVID |
246 | 3 | 3 | |a Une cause émergente de fatigue et de douleurs chroniques : l’affection post-COVID-19 ou COVID long |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 26.06.2023 | ||
500 | |a Date Revised 26.06.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Some individuals who have been infected with SARS-CoV-2 can experience long-term effects from their infection, known as post-COVID conditions, post-acute sequelae of COVID-19 or long COVID. Different underlying mechanisms can lead to long COVID, none of which are mutually exclusive. Lingering symptoms can persist years after SARS-CoV-2 infection, including fatigue, muscle weakness, tachycardia, dyspnea and various neurological symptoms. The symptomatology is partly similar to that reported by people with chronic fatigue syndrome and other unwell studied long-lasting diseases that may occur after other infections. People who have experienced more severe COVID-19 illness are at higher risk of developing long COVID, although anyone who was infected can experience post-COVID conditions. Importantly, unvaccinated individuals are more likely to develop long COVID. Here we review the current knowledge and discuss key findings regarding the epidemiology and physiopathology of long COVID. We briefly review current diagnostic and treatment options that remain so far largely insufficient | ||
650 | 4 | |a Review | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Post-COVID conditions | |
650 | 4 | |a Post-COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a long COVID | |
700 | 1 | |a Guiot, Julien |e verfasserin |4 aut | |
700 | 1 | |a Frippiat, Frédéric |e verfasserin |4 aut | |
700 | 1 | |a Darcis, Gilles |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revue medicale de Liege |d 1947 |g 78(2023), 5-6 vom: Mai, Seite 299-304 |w (DE-627)NLM000044490 |x 0370-629X |7 nnns |
773 | 1 | 8 | |g volume:78 |g year:2023 |g number:5-6 |g month:05 |g pages:299-304 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 78 |j 2023 |e 5-6 |c 05 |h 299-304 |